Spots Global Cancer Trial Database for Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase 3 Study of LY353381 Vs Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.
Official Title: a Phase 3 Randomized Double Blind Evaluation of LY353381 Compared With Tamoxifen in Women With Locally Advanced or Metastatic Breast Cancer.
Study ID: NCT00034125
Conditions
Study Description
Brief Summary: To determine the safety and efficacy of LY353381 when compared to tamoxifen in women with advanced or metastatic breast cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
, Miami, Florida, United States
, Shreveport, Louisiana, United States
, Boston, Massachusetts, United States
, Nashville, Tennessee, United States
, Capital Federal, Buenos Aires, Argentina
, Ciudad De Buenos Aires, , Argentina
, Las Condes, Santiago, Chile
, Providencia, Santiago, Chile
, Ahmedabab, Gujarat, India
, Mexico City, Benito Juarez, Mexico
, Colima, , Mexico
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
